Clinical Trial Update: Medication Repurposing to Stop Cognitive Decline in Dementia

View source ↗

Summary

Karolinska Institutet-led trial on repurposing a medication to halt cognitive decline in Alzheimer's disease and other forms of dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Snippet

Sponsor: Karolinska Institutet | Conditions: Alzheimer Dementia, Dementia Disorders | Status: COMPLETED